COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management.
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management.
复制标题
DOI:
10.3390/diseases9040065
复制
发表时间:
2021-09-22
期刊:
影响因子:
--
通讯作者:
Ullah I
中科院分区:
文献类型:
--
作者:
Yasmin F;Najeeb H;Naeem A;Dapke K;Phadke R;Asghar MS;Shah SMI;De Berardis D;Ullah I
The coronavirus disease 2019 (COVID-19) outbreak has caused significant destruction, claiming over three million lives worldwide. Post SARS-COV-2 invasion, immunosuppression with hyperglycemia and elevated ferritin levels along with steroidal treatment creates a perfect storm for opportunistic infections. There is increasing evidence of mucormycosis co-infection in COVID-19 patients, during or post-treatment. A worse prognosis, a late diagnosis, and limited guidelines of screening and management of COVID-19 associated mucormycosis have made healthcare professionals fear an epidemic alongside a pandemic. This review geographically reports cases of COVID-19 associated mucormycosis (CAM), evaluates characteristics, clinical manifestations, and outcomes of mucormycosis in COVID-19 active or recovered patients. It further describes preventive strategies and recommendations for optimal management therapy that can be adopted worldwide to curtail an impending threat to the healthcare system.
登录
查看更多内容
DOI:
10.1056/nejmoa0901249
发表时间:
2009-08-27
期刊:
The New England journal of medicine
影响因子:
--
作者:
Fazel R;Krumholz HM;Wang Y;Ross JS;Chen J;Ting HH;Shah ND;Nasir K;Einstein AJ;Nallamothu BK
通讯作者:
Nallamothu BK
影响因子:
168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者:
Cao, Bin
影响因子:
1.7
作者:
Castrejón-Pérez AD;Welsh EC;Miranda I;Ocampo-Candiani J;Welsh O
通讯作者:
Welsh O
影响因子:
3.9
作者:
Falci, Diego R;Pasqualotto, Alessandro C
通讯作者:
Pasqualotto, Alessandro C
影响因子:
4.9
作者:
Bicanic, Tihana;Bottomley, Christian;Jarvis, Joseph N.
通讯作者:
Jarvis, Joseph N.